SCH 900776 (MK-8776)

SCH 900776 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SCH 900776 (MK-8776), covering 2017-01-25 to 2017-01-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247) [Phase 1]